SAN DIEGO--(BUSINESS WIRE)--AristaMD, a leading digital health company that provides proprietary eConsult solutions that connect primary care providers (PCPs) with timely, documented specialist insights, announced today the promotion of Pamela Gould, RN, MHA, from vice president of managed care to chief growth officer. Gould brings over 20 years of experience in the healthcare industry with a unique combination of clinical experience as well as proven success in team leadership, strategic planning, market analysis and business development.
“In her time at AristaMD, Pamela has already leveraged her impressive experience in commercializing digital and telehealth solutions to payors to drive rapid growth in the organization’s pipeline,” said Brooke LeVasseur, CEO of AristaMD. “She brings a wealth of knowledge and expertise from a clinical and sales perspective that will be instrumental as we continue to accelerate our growth and expansion across the county.”
As the chief growth officer at AristaMD, Gould will be responsible for reaching and exceeding business revenue targets and managing efforts cross-functionally across health plan, clinic and payor sales teams as the company’s eConsult solution accelerates alongside national telehealth expansion.
“AristaMD’s mission to help minimize the amount of time it takes to gain specialist opinions and achieve better patient outcomes is what truly motivates me,” said Gould. “I’m honored to be a part of this incredible team and I look forward to expanding our commercial footprint in order to move this mission forward.”
Gould’s healthcare career began as a registered nurse and she eventually transitioned her focus to healthcare sales, sales management and training within the specialty pharmacy, provider and payer contracting industries. Prior to joining AristaMD’s growing team, Pamela served as the senior vice president of payer strategies for Happify Health, a digital therapeutic solutions company where she oversaw national sales efforts to managed care insurers.
AristaMD recently secured $24 million completing its Series B funding round, which was co-led by Cigna Ventures and MemorialCare Innovation Fund. The new capital will be used to continue the expansion of the company’s proprietary eConsult platform supporting payors and health systems.
To learn more about AristaMD, please visit www.aristamd.com.
AristaMD is focused on improving patient outcomes through more timely access to specialty care. Its eConsult platform provides a telehealth solution that empowers primary care providers with clinical workup checklists and the ability to conduct electronic consults (also known as eConsults or virtual consults) to significantly improve the patient referral process and allow greater access to timely, high-quality care. Designed to seamlessly integrate into physician referral workflows, the platform allows payers and providers to quickly and cost-effectively launch specialist eConsults using their own specialists or those provided by AristaMD’s board-certified panel of experts. AristaMD’s platform has proven to deliver cost-effective, timely access to specialty care through eConsults, significantly reducing the need for face-to-face visits while increasing patient satisfaction. AristaMD partners with healthcare stakeholders to ensure their success in the transition to value-based care. For additional information, visit aristamd.com, or follow AristaMD on LinkedIn and Twitter.